EUCTR2009-017828-54-IT进行中（未招募）不适用
Cross-reactivity and tolerability of ertapenem in patients with IgE-mediated allergy to -lactams. - ND
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点开始时间: 2010年2月26日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •patients suffering from IgE-mediated allergy to at least one -lactam compound
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
Unknown
4 期
Safety of Ertapenem in Beta-lactam Allergic Patients.IgE-Mediated HypersensitivityAllergyNCT01159379Catholic University of the Sacred Heart30
已完成
2 期
PHARMACOKINETICS AND PHARMACODYNAMICS OF ERTAPENEM IN PATIENTS WITH TUBERCULOSIS10028440tuberculosisTBNL-OMON43693niversitair Medisch Centrum Groningen12
进行中（未招募）
不适用
BLOOD CONCENTRATION OF ERTAPENEM IN PATIENTS WITH TUBERCULOSISTuberculosisEUCTR2012-003386-18-NLMCG
进行中（未招募）
不适用
Pharmacokinetics of ertapenem in patients with severe sepsis and intraabdominal infectioSevere sepsis caused by intraabdominal infection either peritonitis or pancreatitisEUCTR2009-015948-42-EEniversity of Tartu, Faculty of Medicine8
进行中（未招募）
不适用
Pharmacokinetics of ertapenem in a three-weekly dosing regime in patients with end stage renal disease depending on hemodialysisInfection (bacterial)EUCTR2010-020492-23-NLSint Franciscus Gasthuis8